GlassScriptPhysician profile
Mohammed Qintar
NPI 1649530445
$34,778.52
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $24K · 2021: $2,709 · 2022: $2,043 · 2023: $4,653 · 2024: $1,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,658 · Consulting Fee: $1,125 · Travel and Lodging: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,658.32 |
| Consulting Fee | $1,125.00 |
| Travel and Lodging | $937.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $22,289.99 | 2020 | |
| Edwards Lifesciences Corporation | $6,027.62 | 2020-2024 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,287.66 | 2019-2022 | |
| Boston Scientific Corporation | $918.50 | 2021-2024 | Avvigo Guidance System, Watchman Flx, Watchman |
| Medtronic, INC. | $627.86 | 2021-2024 | Corevalve Evolut R |
| Angiodynamics, INC. | $578.62 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $384.39 | 2022-2024 | Camzyos |
| Shockwave Medical, INC | $256.73 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $219.73 | 2022-2023 | Impella |
| Janssen Pharmaceuticals, INC | $174.15 | 2022-2024 | Xarelto |
| Cardiva Medical, INC. | $167.92 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Pfizer INC. | $126.08 | 2022-2024 | |
| Penumbra, INC. | $91.75 | 2024 | Indigo System |
| Inari Medical, INC. | $91.05 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Teleflex LLC | $85.81 | 2022-2023 | Manta, Turnpike |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $73.70 | 2023 | Opsumit, Uptravi |
| Amgen INC. | $69.10 | 2023-2024 | Repatha |
| Terumo Medical Corporation | $68.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $54.15 | 2021-2024 | |
| Atricure, INC. | $43.58 | 2023 | |
| Biosense Webster, INC. | $34.32 | 2023 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $27.69 | 2022-2023 | Brilinta |
| Imperative Care, INC | $19.81 | 2023 | Symphony Catheter |
| Cardiovascular Systems INC. | $15.52 | 2021 | |
| Livanova USA, INC. | $14.89 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.61 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.60 | 2023 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Qintar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.